Cargando…
Medicine quality in high-income countries: The obstacles to comparative prevalence studies
The entry of falsified and substandard medicines into the legitimate pharmaceutical supply chain has negative impacts on healthcare systems, patient safety, and patient access to medicine. The COVID-19 pandemic has highlighted the importance of access to safe medicine through legitimate pharmaceutic...
Autores principales: | Naughton, Bernard David, Akgul, Ebru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413605/ https://www.ncbi.nlm.nih.gov/pubmed/36204504 http://dx.doi.org/10.1177/23992026211052272 |
Ejemplares similares
-
Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014) -
Can We Transplant Conceptual Frameworks of Healthcare Quality Evaluation from Developed Countries into Developing Countries?
por: Ramani, Sudha
Publicado: (2009) -
Internationalization of the Currencies of BRICS Countries
por: Kondratov, D. I.
Publicado: (2021) -
Divergent RNA transcription: A role in promoter unwinding?
por: Naughton, Catherine, et al.
Publicado: (2013) -
Issues in evaluation of cognition in the elderly in developing countries
por: Mathew, R., et al.
Publicado: (2008)